Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,717.26 -2,078.67 (-3.31%) CMC Crypto 200
1,260.94 -97.07 (-7.15%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 277.31 |
| Open | 279.06 |
| Bid | 282.33 x 3100 |
| Ask | 282.62 x 3000 |
| Day's range | 277.79 - 286.00 |
| 52-week range | 261.59 - 431.79 |
| Volume | |
| Avg. volume | 217,380 |
| Market cap | 7.923B |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.69 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 377.80 |
Simply Wall St.Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results
The first-quarter results for Bio-Rad Laboratories, Inc. ( NYSE:BIO ) were released last week, making it a good time to...
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
© 2024 Yahoo. All rights reserved.